Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

Author:  ["Koichi Yoshimura","Hiroki Aoki","Yasuhiro Ikeda","Kozo Fujii","Norio Akiyama","Akira Furutani","Yoshinobu Hoshii","Nobuyuki Tanaka","Romeo Ricci","Tokuhiro Ishihara","Kensuke Esato","Kimikazu Hamano","Masunori Matsuzaki"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Abdominal aortic aneurysm (AAA) is a common disease among elderly people that, when surgical treatment is inapplicable, results in progressive expansion and rupture of the aorta with high mortality. Although nonsurgical treatment for AAA is much awaited, few options are available because its molecular pathogenesis remains elusive. Here, we identify JNK as a proximal signaling molecule in the pathogenesis of AAA. Human AAA tissue showed a high level of phosphorylated JNK. We show that JNK programs a gene expression pattern in different cell types that cooperatively enhances the degradation of the extracellular matrix while suppressing biosynthetic enzymes of the extracellular matrix. Selective inhibition of JNK in vivo not only prevented the development of AAA but also caused regression of established AAA in two mouse models. Thus, JNK promotes abnormal extracellular matrix metabolism in the tissue of AAA and may represent a therapeutic target.

Cite this article

Yoshimura, K., Aoki, H., Ikeda, Y. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11, 1330–1338 (2005). https://doi.org/10.1038/nm1335

View full text

>> Full Text:   Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microv

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis